AstraZeneca PLC

AstraZeneca PLC

AstraZeneca's Dr. Victoria L. Chiou: Advancing Cancer Treatment through Innovative Clinical Trials and Patient-Centric Drug Development

Dr. Victoria L. Chiou, head of clinical excellence and innovation at AstraZeneca, has dedicated her career to revolutionizing cancer treatment. With a strong academic and research background, Chiou has led numerous organizational initiatives that have contributed to business transformation and future readiness through innovation, operational excellence, and sustainability. As a

AstraZeneca PLC

AstraZeneca Surpasses £200 Billion Valuation in Watershed Moment for London's Largest Listed Company

The market capitalisation of AstraZeneca has reached £200 billion for the first time, marking a significant milestone for the Cambridge-based pharmaceuticals group. The company's shares, led by CEO Sir Pascal Soriot, have been on a upward trajectory for years, driven by the launch of blockbuster medicines and ambitious

AstraZeneca PLC

UK Market Cap Ranking: Top 200 Companies

The top 200 companies in the UK, ranked by market capitalization, have been released by Morningstar. The rankings provide a snapshot of the current market landscape, showcasing the largest and most valuable companies in the UK. Key Takeaways: * The top 10 companies in the UK by market capitalization are: Shell,

AstraZeneca PLC

AstraZeneca Completes Acquisition of Amolyt Pharma, Strengthening Rare Disease Division

AstraZeneca has successfully completed the acquisition of Amolyt Pharma, a medical biotechnology company specializing in the development of innovative drugs for the treatment of rare endocrine diseases. The acquisition strengthens the late-stage pipeline of Alexion, the Rare Diseases business of AstraZeneca, and expands the bone metabolism franchise with the investigational

AstraZeneca PLC

AstraZeneca Completes Acquisition of Amolyt Pharma

AstraZeneca has announced the successful completion of its acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. The acquisition bolsters AstraZeneca's rare disease pipeline and expands its bone metabolism franchise with the addition of eneboparatide (AZP-3601), a Phase III investigational

Vaccines

High Prevalence of Delta-Vaccine Breakthrough Infections in Fully Vaccinated Individuals

In a preprint abstract published on medrxiv.org, researchers describe the characteristics of vaccine breakthrough infections (VBI) in fully vaccinated individuals in France during the Delta wave. A total of 1,630 VBI cases from patients fully vaccinated between February and July were included in the study. The analysis revealed

Vaccines

Vietnam Introduces COVID-19 Vaccine Certificates with Electronic QR Codes

The Socialist Republic of Vietnam is set to issue COVID-19 vaccine certificates with electronic QR codes to individuals who have received the primary course of one of eight types of COVID-19 vaccines licensed for use in the country by the health ministry. The certificates, which will be valid for 12

Vaccines

US Health Officials Recommend Pfizer or Moderna Vaccines Over J&J Shot Due to Rare but Serious Blood Clot Risk

US health officials have recommended that most Americans opt for the Pfizer or Moderna COVID-19 vaccines instead of the Johnson & Johnson shot, citing the rare but serious blood clot risk associated with J&J's vaccine. The decision was made by the Centers for Disease Control and

Vaccines

Global Human Papillomavirus Vaccine Market to Reach USD 4.47 Bn by 2026

The global human papillomavirus (HPV) vaccine market is expected to grow at a compound annual growth rate (CAGR) of 6.6 percent, driven by the rising incidence of HPV-associated cancers and increasing demand for prevention. The market is estimated to be USD 3.25 Bn in 2021 and is expected

Vaccines

New Covid-19 Antibody Drug Authorized for US Use Amid Growing Need for Long-Term Protection

Health experts are hailing the recent authorization of a new Covid-19 antibody drug, Evusheld, by the Food and Drug Administration (FDA) as a game-changer for individuals who cannot get adequate protection from vaccination. The AstraZeneca drug is specifically designed for people with serious health problems or allergies who are at

Vaccines

Thailand Removed from Germany's Covid-19 High-Risk List

Travellers from Thailand are now permitted to enter Germany without quarantine restrictions, provided they meet specific requirements, including being fully vaccinated with an approved vaccine and possessing a negative PCR or antigen test result. The development follows Thailand's removal from Germany's list of high-risk countries. The

Vaccines

Insights on COVID-19 Vaccines: A Comprehensive Analysis of Oxford AstraZeneca and mRNA Vaccines

UK health experts have expressed differing views on the effectiveness of COVID-19 vaccines, particularly in relation to the Oxford AstraZeneca and mRNA vaccines. In an interview on BBC Radio 4's The Today Programme, Pascal Soriot, Executive Director and Chief Executive Officer of AstraZeneca, made comments that sparked debate